Polymorphs of an epothilone analog

Details for Australian Patent Application No. 2001281082 (hide)

Owner Bristol-Myers Squibb Company

Inventors Vitez, Imre M.; Guo, Zhenrong; Galella, Michael; Gougoutas, Jack Z.; Favreau, Denis; Malloy, Timothy M.; Dimarco, John D.; Davidovich, Martha

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001281082

PCT Pub. Number WO02/14323

Priority 60225590 16.08.00 US

Filing date 1 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 4 January 2007

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61P 35/00 (2006.01) Antineoplastic agents

C07D 491/044 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

4 January 2007 Application Accepted

  Published as AU-B-2001281082

3 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001281083-Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase

2001281081